Want to see RVP full AI Analyst Report?
RVP Stock Chart & Stats
$0.68
$0.00(0.00%)
At close: 4:00 PM EDT
$0.68
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.60 - $1.14
Previous Close$0.68
Volume5.56K
Average Volume (3M)153.51K
Market Cap
$21.85M
Enterprise Value-$17.26
Total Cash (Recent Filing)$39.87M
Total Debt (Recent Filing)$715.92K
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageMinimal debt reduces refinancing risk and interest-related pressure, giving the company more flexibility to manage operating volatility, fund production needs, or pursue recovery without relying heavily on new borrowing.
Safety-Engineered Product NicheRetractable Technologies serves a structural healthcare need: reducing occupational needlestick injuries. Safety requirements and institutional adoption can support recurring demand for specialized products beyond temporary market conditions.
Narrowing Net LossesThe improvement in net losses indicates some progress toward stabilizing earnings, even though profitability remains negative. If sustained through better cost control or pricing, it could provide a foundation for eventual margin recovery.
Bears Say
Declining RevenueSustained revenue contraction signals weaker product demand, customer volumes, or competitive positioning. Lower sales can reduce manufacturing utilization and make it harder to absorb fixed costs, limiting the path to durable earnings improvement.
Persistent Operating LossesLosses across operating activities show that the current sales base is not covering production and corporate costs. Near-breakeven gross margin also leaves limited protection against pricing pressure, inflation, or weaker utilization.
Negative Cash GenerationOngoing operating and free-cash-flow deficits indicate the business is consuming cash rather than funding itself. Continued burn could eventually constrain investment, increase dependence on financing, and weaken the benefit of its low-debt balance sheet.
Retractable Technologies News
RVP FAQ
What was Retractable Technologies’s price range in the past 12 months?
Retractable Technologies lowest stock price was $0.60 and its highest was $1.14 in the past 12 months.
What is Retractable Technologies’s market cap?
Retractable Technologies’s market cap is $21.85M.
When is Retractable Technologies’s upcoming earnings report date?
Retractable Technologies’s upcoming earnings report date is Nov 17, 2026 which is in 85 days.
How were Retractable Technologies’s earnings last quarter?
Retractable Technologies released its earnings results on Aug 14, 2026. The company reported $0.093 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Retractable Technologies overvalued?
According to Wall Street analysts Retractable Technologies’s price is currently Overvalued.
Does Retractable Technologies pay dividends?
Retractable Technologies does not currently pay dividends.
What is Retractable Technologies’s EPS estimate?
Retractable Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Retractable Technologies have?
Retractable Technologies has 29,937,159 shares outstanding.
What happened to Retractable Technologies’s price movement after its last earnings report?
Retractable Technologies reported an EPS of $0.093 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.156%.
Which hedge fund is a major shareholder of Retractable Technologies?
Currently, no hedge funds are holding shares in RVP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Retractable Technologies
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Technical Analysis
Ownership Overview
55.66% Insiders
2.55% Mutual Funds
2.79% Other Institutional Investors
36.84% Public Companies and
Individual Investors